PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
72 hedge funds and large institutions have $203M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
72
Holders Change
+54
Holders Change %
+300%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
55
Increased
7
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CM
1
Cohanzick Management
Pleasantville,
New York
|
$13.9M |
| 2 |
RA
2
RiverPark Advisors
New York
|
$12.9M |
| 3 |
AC
3
Aristeia Capital
Greenwich,
Connecticut
|
$11.9M |
| 4 |
4
Nomura Holdings
Tokyo,
Japan
|
$11.6M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$17M |
Top Sellers
| 1 |
OCM
1
Oribel Capital Management
New York
|
$2.09M |
| 2 |
BCM
2
Basso Capital Management
Stamford,
Connecticut
|
$0 |
